Sana Biotechnology drops 13% on $75M stock issuance, prices at $3.35
Source: SeekingAlpha
2025-08-07 00:52:55 ET
More on Sana Biotechnology
- Sana: HIP-Modified Islet Cells To Possibly Change Scope Of Type 1 Diabetes Treatment
- Seeking Alpha’s Quant Rating on Sana Biotechnology
- Historical earnings data for Sana Biotechnology
- Financial information for Sana Biotechnology
Read the full article on Seeking Alpha
For further details see:
Sana Biotechnology drops 13% on $75M stock issuance, prices at $3.35
Sana Biotechnology Inc.
NASDAQ: SANA
SANA Trading
7.54% G/L:
$3.28 Last:
2,466,834 Volume:
$3.19 Open:
SANA Latest News
March 13, 2026 09:00:00 am
Sana Biotechnology Announces Continued Positive Clinical Results Through 14 Months from Type 1 Diabetes Study of Islet Cell Transplantation Without Immunosuppression
March 03, 2026 04:05:00 pm
Sana Biotechnology Reports Fourth Quarter and Full Year 2025 Financial Results and Business Updates
SANA Stock Data
$1,021,514,070
186,189,918
2.26%
60
N/A
Biotechnology & Life Sciences
Healthcare
US
Seattle
